Form 4: PetMed Express Director Diana Purcel Reports Acquisition of 7,500 Restricted Stock Units

Director Diana Purcel reports acquisition of 7,500 restricted stock units in PetMed Express, Inc.

Summary

• On August 8, 2024, Diana G Purcel, a director of PetMed Express, Inc., reported the acquisition of 7,500 restricted stock units (RSUs).
• These RSUs were granted under the company's 2024 Omnibus Incentive Plan.
• The RSUs vest on August 8, 2025, contingent upon continued service on the Board of Directors.
• Each RSU represents the right to receive one share of PetMed Express common stock upon vesting.
• Following the transaction, Purcel directly owns 24,375 shares of common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive as it reflects standard executive compensation practices and aligns director interests with shareholder value. There are no indications of negative events or concerns.

Positives

• The grant of restricted stock units aligns the director's interests with those of the shareholders, incentivizing continued service and contribution to the company's success.

Future Outlook

The vesting of the RSUs is contingent upon continued service on the Board of Directors through August 8, 2025.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders, such as directors and officers, ensuring fair market practices.

Stakeholder Impact

• The grant of RSUs aligns the director's interests with those of the shareholders.

Key Dates